1. Home
  2. CRVS vs FSBW Comparison

CRVS vs FSBW Comparison

Compare CRVS & FSBW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRVS
  • FSBW
  • Stock Information
  • Founded
  • CRVS 2014
  • FSBW 1936
  • Country
  • CRVS United States
  • FSBW United States
  • Employees
  • CRVS N/A
  • FSBW N/A
  • Industry
  • CRVS Biotechnology: Pharmaceutical Preparations
  • FSBW Banks
  • Sector
  • CRVS Health Care
  • FSBW Finance
  • Exchange
  • CRVS Nasdaq
  • FSBW Nasdaq
  • Market Cap
  • CRVS 305.4M
  • FSBW 324.8M
  • IPO Year
  • CRVS 2016
  • FSBW 2012
  • Fundamental
  • Price
  • CRVS $5.75
  • FSBW $42.71
  • Analyst Decision
  • CRVS Strong Buy
  • FSBW Hold
  • Analyst Count
  • CRVS 4
  • FSBW 1
  • Target Price
  • CRVS $15.00
  • FSBW $44.00
  • AVG Volume (30 Days)
  • CRVS 518.7K
  • FSBW 17.5K
  • Earning Date
  • CRVS 08-07-2025
  • FSBW 10-21-2025
  • Dividend Yield
  • CRVS N/A
  • FSBW 2.62%
  • EPS Growth
  • CRVS N/A
  • FSBW N/A
  • EPS
  • CRVS N/A
  • FSBW 4.15
  • Revenue
  • CRVS N/A
  • FSBW $139,676,000.00
  • Revenue This Year
  • CRVS N/A
  • FSBW $9.62
  • Revenue Next Year
  • CRVS N/A
  • FSBW $5.35
  • P/E Ratio
  • CRVS N/A
  • FSBW $10.28
  • Revenue Growth
  • CRVS N/A
  • FSBW 0.61
  • 52 Week Low
  • CRVS $2.54
  • FSBW $34.61
  • 52 Week High
  • CRVS $10.00
  • FSBW $49.15
  • Technical
  • Relative Strength Index (RSI)
  • CRVS 65.10
  • FSBW 61.80
  • Support Level
  • CRVS $5.28
  • FSBW $41.40
  • Resistance Level
  • CRVS $5.64
  • FSBW $42.89
  • Average True Range (ATR)
  • CRVS 0.30
  • FSBW 1.14
  • MACD
  • CRVS 0.03
  • FSBW 0.32
  • Stochastic Oscillator
  • CRVS 77.70
  • FSBW 95.42

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

About FSBW FS Bancorp Inc.

FS Bancorp Inc is the holding company of 1st Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking; and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.

Share on Social Networks: